(Q37885803)

24 August 2017

1 reference

title

Cryptogenic chronic hepatitis and its changing guise in adults (English)

1 reference

24 August 2017

1 reference

Albert J Czaja

1

1 reference

24 August 2017

7 June 2011

1 reference

Digestive Diseases and Sciences

24 August 2017

1 reference

24 August 2017

56

1 reference

24 August 2017

12

1 reference

24 August 2017

3421-3438

1 reference

https://scigraph.springernature.com/pub.10.1007/s10620-011-1769-9

24 August 2017

0 references

cites work

Clinical features and prognostic implications of severe corticosteroid-treated cryptogenic chronic active hepatitis

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1769-9

Establishment of standardised SLA/LP immunoassays: specificity for autoimmune hepatitis, worldwide occurrence, and clinical characteristics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1769-9

Autoantibodies to asialoglycoprotein receptor (ASGPR) measured by a novel ELISA--revival of a disease-activity marker in autoimmune hepatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1769-9

Cytochromes P450 and uridine triphosphate-glucuronosyltransferases: model autoantigens to study drug-induced, virus-induced, and autoimmune liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1769-9

Cryptogenic cirrhosis: clinical characterization and risk factors for underlying disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1769-9

Cryptogenic cirrhosis and NAFLD: are they related?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1769-9

Cryptogenic cirrhosis: what are we missing?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1769-9

Does the heterozygous state of alpha-1 antitrypsin deficiency have a role in chronic liver diseases? Interim results of a large case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1769-9

TT-virus infection in North American blood donors, patients with fulminant hepatic failure, and cryptogenic cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1769-9

Autochthonous hepatitis E in Southwest England: natural history, complications and seasonal variation, and hepatitis E virus IgG seroprevalence in blood donors, the elderly and patients with chronic liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1769-9

GB virus-C infection in type 1 autoimmune hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1769-9

Pathological and virological findings in patients with persistent hypertransaminasaemia of unknown aetiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1769-9

Are hepatitis G virus and TT virus involved in cryptogenic chronic liver disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1769-9

Investigation of SEN Virus Infection in Patients with Cryptogenic Acute Liver Failure, Hepatitis‐Associated Aplastic Anemia, or Acute and Chronic Non–A–E Hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1769-9

Cryptogenic liver disease in HIV-seropositive men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1769-9

Cryptogenic liver diseases: sailing by sight from HIV co-infection with hepatitis viruses to HIV mono-infection through the Pillars of Hercules

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1769-9

Anti tissue transglutaminase antibodies as predictors of silent coeliac disease in patients with hypertransaminasaemia of unknown origin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1769-9

Celiac disease in patients with severe liver disease: gluten-free diet may reverse hepatic failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1769-9

Liver abnormalities in celiac disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1769-9

Pathogenesis and clinical significance of liver injury in celiac disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1769-9

Frequency and significance of antibody to hepatitis C virus in severe corticosteroid-treated cryptogenic chronic active hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1769-9

Antibody to hepatitis C virus in cryptogenic chronic liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1769-9

Prevalence of antibodies to hepatitis C virus among patients with cryptogenic chronic hepatitis and cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1769-9

Frequency of antibody to hepatitis C virus in asymptomatic HBsAg-negative chronic active hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1769-9

Seroprevalence of hepatitis C virus nucleocapsid antibodies in patients with cryptogenic chronic liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1769-9

Surreptitious hepatitis C virus (HCV) infection detected in the majority of patients with cryptogenic chronic hepatitis and negative HCV antibody tests.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1769-9

Prevalence of obesity and diabetes in patients with cryptogenic cirrhosis: a case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1769-9

The natural history of nonalcoholic steatohepatitis: a follow-up study of forty-two patients for up to 21 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1769-9

Non-alcoholic fatty liver disease: an overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1769-9

Non-alcoholic fatty liver disease: an overview of prevalence, diagnosis, pathogenesis and treatment considerations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1769-9

Review article: diagnosis and treatment of non-alcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1769-9

End-stage nonalcoholic fatty liver disease: evaluation of pathomorphologic features and relationship to cryptogenic cirrhosis from study of explant livers in a living donor liver transplant program

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1769-9

Could post-liver transplantation course be helpful for the diagnosis of so called cryptogenic cirrhosis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1769-9

Corticosteroid-responsive cryptogenic chronic hepatitis: evidence for seronegative autoimmune hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1769-9

Steroid treatment for severe acute cryptogenic hepatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1769-9

Presumed cryptogenic liver disease in Germany: High prevalence of autoantibody-negative autoimmune hepatitis, low prevalence of NASH, no evidence for occult viral etiology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1769-9

Frequency, behavior, and prognostic implications of antimitochondrial antibodies in type 1 autoimmune hepatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1769-9

Cirrhosis of undefined pathogenesis: absence of evidence for unknown viruses or autoimmune processes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1769-9

Hepatic cirrhosis: a clinico-pathological review of 520 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1769-9

The clinical spectrum of chronic liver disease in children presenting to a tertiary level teaching hospital in New Delhi

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1769-9

Should a liver biopsy be done in patients with subclinical chronically elevated transaminases?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1769-9

Keratin 8 mutations in patients with cryptogenic liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1769-9

Orthotopic liver transplantation for autoimmune hepatitis and cryptogenic chronic hepatitis in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1769-9

Anti-tissue transglutaminase antibodies in patients with abnormal liver tests: is it always coeliac disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1769-9

Absence of hemochromatosis associated Cys282Tyr HFE gene mutation and low frequency of hemochromatosis phenotype in nonalcoholic chronic liver disease patients in India.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1769-9

Autoimmune hepatitis. Part B: diagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1769-9

Advances in the diagnosis, pathogenesis, and management of autoimmune hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1769-9

Diagnosis and management of autoimmune hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1769-9

Autoimmune hepatitis. Part A: pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1769-9

Simplified criteria for the diagnosis of autoimmune hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1769-9

International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1769-9

Performance parameters of the diagnostic scoring systems for autoimmune hepatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1769-9

Autoimmune hepatitis with centrilobular necrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1769-9

Fulminant hepatic failure as the initial presentation of acute autoimmune hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1769-9

Diagnostic and therapeutic implications of bile duct injury in autoimmune hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1769-9

Is severe cryptogenic chronic hepatitis similar to autoimmune hepatitis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1769-9

Autoantibodies as prognostic markers in autoimmune liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1769-9

High-titer antineutrophil cytoplasmic antibodies in type-1 autoimmune hepatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1769-9

Antineutrophil cytoplasmic antibodies in chronic liver diseases: prevalence, titre, specificity and IgG subclass.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1769-9

Hepatitis C virus is not recoverable from liver tissue in cryptogenic cirrhosis: failure to identify hepatitis C virus-RNA using reverse transcription-mediated polymerase chain reaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1769-9

Chronic cryptogenic hepatitis in childhood is unrelated to hepatitis G virus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1769-9

Natural history of unexplained chronic hepatitis after liver transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1769-9

Nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1769-9

Hyperferritinemia is a risk factor for steatosis in chronic liver disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1769-9

Development of nonalcoholic fatty liver disease after orthotopic liver transplantation for cryptogenic cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1769-9

Expanding the natural history of nonalcoholic steatohepatitis: from cryptogenic cirrhosis to hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1769-9

Metabolic factors and non-alcoholic fatty liver disease as co-factors in other liver diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1769-9

Occult hepatitis B virus infection and cryptogenic chronic hepatitis in an area with intermediate prevalence of HBV infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1769-9

Hepatitis E: an emerging infection in developed countries.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1769-9

Lack of hepatitis E virus infection in HIV patients with advanced immunodeficiency or idiopathic liver enzyme elevations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1769-9

Acute hepatitis E by a new isolate acquired in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1769-9

Torque Teno Virus--cause of viral liver disease following liver transplantation: a case report.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1769-9

Torque teno virus infection in hemodialysis patients in North India

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1769-9

G to A hypermutation of TT virus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1769-9

SEN virus: epidemiology and characteristics of a transfusion-transmitted virus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1769-9

High frequency of SEN virus infection in thalassemic patients and healthy blood donors in Iran

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1769-9

Update on hereditary hemochromatosis and the HFE gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1769-9

Population screening for hemochromatosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1769-9

Nonexpressing homozygotes for C282Y hemochromatosis: minority or majority of cases?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1769-9

Penetrance of 845G--> A (C282Y) HFE hereditary haemochromatosis mutation in the USA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1769-9

Liver diseases in the hemochromatosis and iron overload screening study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1769-9

Phenotypic characteristics and diagnoses of patients referred to an iron overload clinic

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1769-9

Hemochromatosis in Italy in the last 30 years: role of genetic and acquired factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1769-9

Ferroportin disease: a systematic meta-analysis of clinical and molecular findings

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1769-9

Hepatic iron, liver steatosis and viral genotypes in patients with chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1769-9

Serum ferritin as a predictor of treatment outcome in patients with chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1769-9

Elevated hepatic iron: a confounding factor in chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1769-9

The H63D genetic variant of the HFE gene is independently associated with the virological response to interferon and ribavirin therapy in chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1769-9

Iron accumulation in alcoholic liver diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1769-9

HFE mutations in alpha-1-antitrypsin deficiency: an examination of cirrhotic explants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1769-9

Heterozygous alpha 1-antitrypsin deficiency and cirrhosis in adults, a fortuitous association

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1769-9

Heterozygosity of alpha 1-antitrypsin: a health risk?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1769-9

Alpha-1-antitrypsin deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1769-9

Late-onset Wilson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1769-9

Three atypical cases of Wilson disease: assessment of the Leipzig scoring system in making a diagnosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1769-9

Diagnosis and phenotypic classification of Wilson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1769-9

Diagnosis and treatment of Wilson disease: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1769-9

Screening for Wilson disease in acute liver failure: a comparison of currently available diagnostic tests

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1769-9

Wilson disease: current status and the future

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1769-9

The Wilson disease gene is a copper transporting ATPase with homology to the Menkes disease gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1769-9

Frequency and significance of anti-gliadin and anti-endomysial antibodies in autoimmune hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1769-9

Body mass index, waist circumference, and health risk: evidence in support of current National Institutes of Health guidelines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1769-9

Histological findings in chronic hepatitis C with autoimmune features

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1769-9

Consensus recommendations for managing asymptomatic persistent non-virus non-alcohol related elevation of aminotransferase levels: suggestions for diagnostic procedures and monitoring

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1769-9

Drug-induced autoimmune-like hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1769-9

Frequency and significance of chronic ulcerative colitis in severe corticosteroid-treated autoimmune hepatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1769-9

Prevalence of sclerosing cholangitis in adults with autoimmune hepatitis: evaluating the role of routine magnetic resonance imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1769-9

Prevalence of sclerosing cholangitis in adults with autoimmune hepatitis: a prospective magnetic resonance imaging and histological study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1769-9

Inherited metabolic disease of the liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1769-9

Autoantibodies in the Diagnosis and Management of Liver Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1769-9

Optimizing diagnosis from the medical liver biopsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1769-9

Mutation of human keratin 18 in association with cryptogenic cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1769-9

Familial Mediterranean fever and cryptogenic cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1769-9

Leptin: a review of its peripheral actions and interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1769-9

Drug Insight: the role of leptin in human physiology and pathophysiology--emerging clinical applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1769-9

Relationship between unexplained elevations in alanine aminotransferase and serum leptin in U.S. adults: results from the Third National Health and Nutrition Examination Survey (NHANES III).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1769-9

Low circulating levels of dehydroepiandrosterone in histologically advanced nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1769-9

Immune phenotype of chronic liver disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1769-9

Preferential X chromosome loss but random inactivation characterize primary biliary cirrhosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1769-9

Susceptibility to autoimmune chronic active hepatitis: human leukocyte antigens DR4 and A1-B8-DR3 are independent risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1769-9

Associations between alleles of the major histocompatibility complex and type 1 autoimmune hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1769-9

Genetic factors affecting the occurrence, clinical phenotype, and outcome of autoimmune hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1769-9

Outcomes of liver transplantation for cryptogenic cirrhosis: a single-center study of 71 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1769-9

De novo cryptogenic hepatitis after sustained eradication of hepatitis C following liver transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1769-9

Treatment strategies in autoimmune hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1769-9

Current and future treatments of autoimmune hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1769-9

Randomized controlled trial testing the effects of weight loss on nonalcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1769-9

Physical activity recommendations, exercise intensity, and histological severity of nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1769-9

Cigarette smoking exacerbates nonalcoholic fatty liver disease in obese rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1769-9

Insufficient Sleep Undermines Dietary Efforts to Reduce Adiposity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1769-9

Management of hepatocellular carcinoma: An update

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1769-9

Antibodies to conformational epitopes of soluble liver antigen define a severe form of autoimmune liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1769-9

Coeliac disease hidden by cryptogenic hypertransaminasaemia

21 January 2018

2 references

https://api.crossref.org/works/10.1007%2FS10620-011-1769-9

21 January 2018

12 December 2020

Pediatric liver transplantation in Iran: Evaluation of the first 50 cases

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1769-9

[Hereditary hemochromatosis, alpha-1-antitrypsin deficiency and Wilson's disease. Pathogenesis, clinical findings and pathways to diagnosis]

21 January 2018

1 reference

12 December 2020

C282Y mutation and hepatic iron status in hepatitis C and cryptogenic cirrhosis

1 reference

12 December 2020

Frequency and significance of antibodies to liver/kidney microsome type 1 in adults with chronic active hepatitis

1 reference

12 December 2020

Role of hemochromatosis genes in chronic hepatitis C.

1 reference

12 December 2020

Performance parameters of the conventional serological markers for autoimmune hepatitis

1 reference

12 December 2020

Hereditary hemochromatosis: pathogenesis, diagnosis, and treatment

1 reference

12 December 2020

Recurrence of nonalcoholic steatohepatitis after liver transplantation

1 reference

12 December 2020

Inherited metabolic disease of the liver

1 reference

12 December 2020

Behavior and significance of autoantibodies in type 1 autoimmune hepatitis

1 reference

12 December 2020

Evidence for non-HFE linked hemochromatosis in Asian Indians

1 reference

12 December 2020

Significance of HLA DR4 in type 1 autoimmune hepatitis

1 reference

12 December 2020

Nonalcoholic steatohepatitis: An expanded clinical entity

1 reference

12 December 2020

Validation of scoring system for diagnosis of autoimmune hepatitis

1 reference

12 December 2020

New mutations in the Wilson disease gene, ATP7B: implications for molecular testing

1 reference

12 December 2020

Host- and disease-specific factors affecting steatosis in chronic hepatitis C

1 reference

12 December 2020

Sensitivity, specificity, and predictability of biopsy interpretations in chronic hepatitis

1 reference

12 December 2020

High prevalence but low pathogenicity of hepatitis G virus infection in Italian patients with genetic haemochromatosis

1 reference

12 December 2020

Autoimmune cholangitis within the spectrum of autoimmune liver disease

1 reference

12 December 2020

Nonstandard antibodies as prognostic markers in autoimmune hepatitis

1 reference

12 December 2020

Significance of molecular identification of hepatitis C virus RNA in diagnosis of cryptogenic hepatitis in children.

1 reference

12 December 2020

Wilson's disease: varied hepatic presentations

1 reference

12 December 2020

Autoantibodies in autoimmune liver disease

1 reference

12 December 2020

NASH and cryptogenic cirrhosis: a histological analysis.

1 reference

12 December 2020

Auto-immune features in patients with idiopathic chronic active hepatitis who are seronegative for conventional auto-antibodies

1 reference

12 December 2020

Heterozygous MZ alpha-1-antitrypsin deficiency in adults with chronic liver disease

1 reference

12 December 2020

The nature and prognosis of severe cryptogenic chronic active hepatitis.

1 reference

12 December 2020

Alpha-1-Antitrypsin MZ Phenotype and Cryptogenic Chronic Liver Disease in Adults

1 reference

12 December 2020

Nonalcoholic fatty liver disease after liver transplantation for cryptogenic cirrhosis or nonalcoholic fatty liver disease

1 reference

12 December 2020

Hemochromatosis gene and nonalcoholic fatty liver disease: a systematic review and meta-analysis.

1 reference

12 December 2020

Prevalence of GB virus-C/hepatitis G virus infection in patients with cryptogenic chronic liver disease and in patients with primary biliary cirrhosis or Wilson's disease

1 reference

12 December 2020

SEN virus infection in Egyptian patients with chronic hepatitis C and patients undergoing hemodialysis

1 reference

12 December 2020

Hepatocellular carcinoma in patients with cryptogenic cirrhosis

1 reference

12 December 2020

Diagnosis of Wilson's disease: a comprehensive review

1 reference

12 December 2020

Revealing the cause of cryptogenic cirrhosis by posttransplant liver biopsy

1 reference

12 December 2020

Antibodies to soluble liver antigen/liver pancreas and HLA risk factors for type 1 autoimmune hepatitis

1 reference

12 December 2020

Distinctive clinical phenotype and treatment outcome of type 1 autoimmune hepatitis in the elderly

1 reference

12 December 2020

Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults--The Evidence Report. National Institutes of Health

1 reference

12 December 2020

Clinicopathological features of acute-onset autoimmune hepatitis

1 reference

12 December 2020

Findings on liver biopsy to investigate abnormal liver function tests in the absence of diagnostic serology

1 reference

12 December 2020

Cryptogenic liver disease in the United States: further evidence for non-A, non-B, and non-C hepatitis

1 reference

12 December 2020

Iron levels in hepatocytes and portal tract cells predict progression and outcomes of patients with advanced chronic hepatitis C.

1 reference

12 December 2020

A novel histological lesion in glucocorticoid-responsive chronic hepatitis

1 reference

12 December 2020

Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease

1 reference

12 December 2020

Detection of alpha-1-antitrypsin in hepatocytes in acute and chronic hepatitis

1 reference

12 December 2020

Prevalence of coeliac disease in unexplained chronic hypertransaminasemia.

1 reference

12 December 2020

Sex and acquired cofactors determine phenotypes of ferroportin disease

1 reference

12 December 2020

Clinical & molecular characterization of human TT virus in different liver diseases

1 reference

12 December 2020

Heterozygous MZ alpha 1-antitrypsin deficiency in adults with chronic active hepatitis and cryptogenic cirrhosis

1 reference

12 December 2020

High prevalence of the H1069Q mutation in East German patients with Wilson disease: rapid detection of mutations by limited sequencing and phenotype-genotype analysis

1 reference

12 December 2020

Liver dysfunction in celiac disease.

1 reference

12 December 2020

Liver disease and intermediate alpha 1-antitrypsin deficiency

1 reference

12 December 2020

Frequency of concurrent autoimmune disorders in patients with autoimmune hepatitis: effect of age, gender, and genetic background.

1 reference

12 December 2020

Leptin, insulin resistance, and liver fibrosis in human nonalcoholic fatty liver disease

1 reference

12 December 2020

Does hepatocellular carcinoma in non-alcoholic steatohepatitis exist in cirrhotic and non-cirrhotic patients?

1 reference

12 December 2020

Increased risk of chronic liver failure in adults with heterozygous alpha1-antitrypsin deficiency

1 reference

12 December 2020

Characterization of the liver cytosol antigen type 1 reacting with autoantibodies in chronic active hepatitis

1 reference

12 December 2020

Alpha-1-antitrypsin deficiency--a cause of cryptogenic liver disease in the elderly

1 reference

12 December 2020

Roles of iron and HFE mutations on severity and response to therapy during retreatment of advanced chronic hepatitis C

1 reference

12 December 2020

Celiac disease-associated autoimmune cholangitis

1 reference

12 December 2020

Comparability of probable and definite autoimmune hepatitis by international diagnostic scoring criteria

1 reference

12 December 2020

Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease

1 reference

12 December 2020

Frequency and significance of antibodies to soluble liver antigen/liver pancreas in variant autoimmune hepatitis

1 reference

12 December 2020

Frequency and significance of phenotypes for alpha1-antitrypsin deficiency in type 1 autoimmune hepatitis

1 reference

12 December 2020

An evaluation of long-term outcomes after liver transplantation for cryptogenic cirrhosis

1 reference

12 December 2020

Histologic spectrum of cryptogenic chronic liver disease and comparison with chronic autoimmune and chronic type C hepatitis

1 reference

12 December 2020

Risk of hepatobiliary disease in adults with severe alpha 1-antitrypsin deficiency (PiZZ): is chronic viral hepatitis B or C an additional risk factor for cirrhosis and hepatocellular carcinoma?

1 reference

12 December 2020

The role of iron overload and HFE gene mutations in the era of pegylated interferon and ribavirin treatment of chronic hepatitis C.

1 reference

12 December 2020

Diagnostic accuracy of atypical p-ANCA in autoimmune hepatitis using ROC- and multivariate regression analysis

1 reference

12 December 2020

Alpha-1-antitrypsin deficiency: diagnosis and treatment

1 reference

12 December 2020

Drug-Induced Liver Disease

1 reference

12 December 2020

Common mutations of ATP7B in Wilson disease patients from Hungary

1 reference

12 December 2020

The role of autoantibodies as diagnostic markers of autoimmune hepatitis

1 reference

12 December 2020

Alpha 1-antitrypsin deficiency presenting as cryptogenic cirrhosis in adults over 50.

1 reference

12 December 2020

Liver transplantation of patients with cryptogenic cirrhosis: clinical characteristics and outcome

1 reference

12 December 2020

SEN virus infection in Egyptian patients undergoing maintenance hemodialysis: prevalence and clinical importance.

1 reference

12 December 2020

Clinical characteristics of patients with cryptogenic liver cirrhosis in Okinawa, Japan

1 reference

12 December 2020

Prevalence of hypertransaminasemia in adult celiac patients and effect of gluten-free diet

1 reference

12 December 2020

Manifestations of nonsuppurative cholangitis in chronic hepatobiliary diseases: morphologic spectrum, clinical correlations and terminology

1 reference

12 December 2020

1 reference

12 December 2020

Prevalence of anti-HCV in cryptogenic cirrhosis in a suburban Detroit community

1 reference

12 December 2020

Gender effects and synergisms with histocompatibility leukocyte antigens in type 1 autoimmune hepatitis

1 reference

12 December 2020

10.1007/S10620-011-1769-9

Identifiers

DOI

1 reference

release_fpi6ksukknehllhd54bdqkol3i

24 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/fpi6ksukknehllhd54bdqkol3i

24 November 2022

mapped directly with Wikidata item

PubMed ID

21647651

1 reference

PubMed ID

21647651